Skip to content. Skip to navigation
Sections
Personal tools
You are here: Home Events Practical HPLC in Pharmaceutical Analysis
Navigation
Log in


Forgot your password?
New user?
Site Search
 
Search only the current folder (and sub-folders)
 
Document Actions

Practical HPLC in Pharmaceutical Analysis

Type Course
Language English
Date August 17, 2009
from 08:30 am to 05:00 pm
Venue Crowne Plaza Hotel - The Hamilton
1001 14th St NW
Washington, DC 20005
US
Chemistry Specialties
  • other
Chemistry Techniques
  • other
Contact
American Chemical Society
1155 Sixteenth Street, NW
Washington, DC 20036
US
(800) 227-5558

shortcourses@acs.org
Add event to calendar vCal (Windows, Linux)
iCal (Mac OS X)
by Daniel Fishman last modified 05-21-09 05:42 AM

Analytical procedures are used to assure that the drug product meets applicable standards of identity, strength, quality, and purity during its expiration dating. The majority of analytical methods used in pharmaceutical development are HPLC analyses. cGMPs require stability indicating methods to monitor the drug product’s stability profiles. Therefore, method development and validation significantly impact the drug development process. Additional expectations are also placed on the monitoring of impurities and degradation products. This course focuses on reversed-phase analysis of drug substances and drug products (small molecule). It will discuss forced degradation strategies to develop stability-indicating analytical procedures. A review of ICH guidelines on validation and impurities will be done to help Pharmaceutical Manufacturers to gain better understanding of method validation by phases of drug development and regulatory expectations through a review of warning letters.

Key Topics * Design your forced degradation studies to support method specificity * Review cGMP regulations that govern the pharmaceutical laboratory * Understand ICH regulations surrounding method validation and stability-indicating procedures (Q2A&B) * Impact of developing stability indicating methods * Understand Q3 for impurities monitoring

Speakers

Kim Huynh-Ba is the Technical Director of Pharmalytik Consulting and Training Services (www.pharmalytik.com). With over twenty years of experience in various analytical areas of pharmaceutical development and a primary focus in stability sciences, she specializes in analytical development, stability, outsourcing and technology transfer management. She has been involved with several projects harmonizing and optimizing analytical best practices in several companies, including those under Consent Decree. Kim has authored numerous technical publications and is invited as a frequent speaker at national and international conferences. Since 2001, she has conducted training activities on cGMP compliance and quality issues for national organizations such as ACS, AAPS, IIR, SWE, IVT and CBI. She is also the founder of the AAPS Stability Focus Group, and is an active member of AAPS, PSDG, as well as serving on the Governing Board of Eastern Analytical Symposium (EAS). She also is EAS 2008 Short Course Chair and AAPS 2008 APQ Distance Learning Chair.

Session titles

Agenda I. Regulatory Aspects in Pharmaceutical Testing * Impact of analytical testing in the drug development process * cGMP requirements for analytical test methods * Review ICH Q2 A&B guidelines for method development/validation * Design method specificity through forced degradation activities II. Key Concepts in Reversed-phase LC * An overview of key HPLC concepts * Mobile phase parameters (pH) and method orthogonality * How to select HPLC columns to support specificity III. Best Practices in HPLC Method Development * Stress studies to challenge stability-indicating power of analytical procedures * Review strategies and modern method development trends * Method optimization to meet ICH reporting guidelines * Phase-appropriate method development and validation IV. Managing Validation Data for Quality and Compliance * Recent FDA 483 observations related to analytical method validation * Overview of Q3 for impurities monitoring * System suitability of HPLC test methods

More information about this event…

« May 2013 »
Su Mo Tu We Th Fr Sa
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31
Sponsors
Web Search
 

Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: